Investment
Features
FeesSafety
Academy
More
Pluang+

Strategy buys 4,871 Bitcoin for $330M, resuming aggressive accumulation after 2-week pause.

Market News
06 Apr 2026
Blockonomi
View Source
Bullish
pluang ai news

Strategy resumed its Bitcoin buying spree by acquiring 4,871 BTC at an average price of $67,718 each, spending $329.9 million between April 1-5, 2026. This purchase ended a two-week break in their 13-week consecutive buying streak. Despite holding 766,970 Bitcoins at an average cost of $75,644, the company reported a $14.46 billion unrealized loss on its digital assets in Q1 2026, offset partly by a $2.42 billion deferred tax benefit. Bitcoin's price has dropped from over $125,000 in late 2025 to around $69,000 amid market volatility, but Strategy's market value still trades at a 9% premium to its Bitcoin holdings' value.

More News

Global automotive microcontrollers market to reach $34.31B by 2035, driven by ADAS, electrification, and software-defined vehicles.

Global automotive microcontrollers market to reach $34.31B by 2035, driven by ADAS, electrification, and software-defined vehicles.

The global automotive microcontrollers market is projected to grow from USD 15.49 billion in 2025 to USD 34.31 billion by 2035, at a CAGR of 8.28%. Growth is fueled by increasing adoption of advanced driver-assistance systems (ADAS), vehicle electrif...

Market News
Bullish
3 hours ago
B&M's Q1 update splits analysts as Deutsche Bank upgrades but Panmure Liberum downgrades on growth doubts

B&M's Q1 update splits analysts as Deutsche Bank upgrades but Panmure Liberum downgrades on growth doubts

B&M European Value Retail's first-quarter update has divided analysts, with Deutsche Bank upgrading the stock to 'hold' citing stabilizing profit margins and a sensible turnaround strategy by new CEO Tjeerd Jegen. Deutsche Bank raised its profit fore...

Analyst Insights
Neutral
4 hours ago
Telo Genomics reports positive interim results for blood test predicting relapse risk in multiple myeloma patients.

Telo Genomics reports positive interim results for blood test predicting relapse risk in multiple myeloma patients.

Telo Genomics announced positive interim results from a clinical study analyzing blood samples of multiple myeloma patients to predict relapse risk using 3D telomere analysis. The test showed strong predictive accuracy, potentially offering a less in...

Market News
Bullish
4 hours ago
Meta alerts parents if teens discuss self-harm with its AI chatbot, plans emergency contact feature.

Meta alerts parents if teens discuss self-harm with its AI chatbot, plans emergency contact feature.

Meta now notifies parents if their teen talks about suicide or self-harm with its AI chatbot and is developing a feature to contact emergency services if risk is detected. This move addresses concerns about AI chatbots handling crisis conversations, ...

Market News
Neutral
4 hours ago
Ohio EPA advances Graphite One's air permit for Ohio graphite facility to technical review stage

Ohio EPA advances Graphite One's air permit for Ohio graphite facility to technical review stage

Graphite One's air permit application for its planned Active Anode Materials facility in Conneaut, Ohio, has been accepted as administratively complete by the Ohio EPA, moving into technical review. This is a key step toward obtaining the air permit ...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App